Premature Birth
Recent clinical, regulatory, research and industry developments relating to this disease.
Maternal gut microbiota in the health of mothers and offspring: from the perspective of immunology.
The Role of Genetics in Preterm Birth.
The Female Vaginal Microbiome in Health and Bacterial Vaginosis.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 4 clinical trials expected to report results, the earliest in Q4 2026.
- Q4 2026Single Dose of Antenatal Corticosteroids (SNACS) Randomized Controlled Trial for Pregnancies at Risk of Preterm Delivery: To Keep Babies and Children Safe
- Q1 2027Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants - The ACEDUCT Trial
- Q4 2028Cervical Cerclage for Short Cervix at 24-26 Weeks of Gestation: a Randomized Controlled Trial
- Q2 2029Azithromycin and Ampicillin for Late PPROM
Clinical MilestonesViewHide
- 2026-02-24Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm BirthResults posted
- 2026-05-29Cervical Cerclage for Short Cervix at 24-26 Weeks of Gestation: a Randomized Controlled TrialResults expected Q4 2028
- 2026-04-06Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants - The ACEDUCT TrialResults expected Q1 2027
- 2026-01-07Single Dose of Antenatal Corticosteroids (SNACS) Randomized Controlled Trial for Pregnancies at Risk of Preterm Delivery: To Keep Babies and Children SafeResults expected Q4 2026
- 2025-12-18Azithromycin and Ampicillin for Late PPROMResults expected Q2 2029
- 2025-12-31Prophylactic Minimally Invasive Surfactant EvaluationPrimary completion
- 2026-05-29ClinicalCervical Cerclage for Short Cervix at 24-26 Weeks of Gestation: a Randomized Controlled TrialResults expected Q4 2028
- 2026-04-06ClinicalCo-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants - The ACEDUCT TrialResults expected Q1 2027
- 2026-02-24ClinicalVaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm BirthResults posted
- 2026-01-07ClinicalSingle Dose of Antenatal Corticosteroids (SNACS) Randomized Controlled Trial for Pregnancies at Risk of Preterm Delivery: To Keep Babies and Children SafeResults expected Q4 2026
- 2025-12-31ClinicalProphylactic Minimally Invasive Surfactant EvaluationPrimary completion
- 2025-12-18ClinicalAzithromycin and Ampicillin for Late PPROMResults expected Q2 2029
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Premature Birth8
- Microbiota3
- Autism Spectrum Disorder1
- Birth Weight1
- Cervix Uteri1
- Communicable Diseases1
- COVID-191
- Cytokines1
Leading journals6
- Frontiers in immunology2
- American journal of obstetrics and gynecology1
- European child & adolescent psychiatry1
- Frontiers in cellular and infection microbiology1
- JAMA1
- PLoS medicine1
Leading researchers8
- Chen X2
- Lu X2
- Åden U1
- Alexander EK1
- Auvinen J1
- Ayers S1
- Bassols J1
- Bliddal S1
Affiliations (unnormalised)6
- Finnish Institute for Health and Welfare2
- Karolinska Institutet2
- Academic Center for Thyroid Diseases1
- Almazov National Medical Research Centre1
- and Clinical Pharmacology1
- Center for Molecular Medicine1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Premature birth is childbirth that occurs before 37 completed weeks of pregnancy. It is a complex obstetric outcome and is a major cause of illness and death in early childhood.
The literature describes premature birth as multifactorial rather than due to a single cause. Reported contributors include genetic variation and maternal conditions such as thyroid dysfunction, thyroid autoimmunity, and bacterial vaginosis-associated vaginal microbiome disruption.
Published genetic studies implicate inflammatory, immunological, tissue-remodeling, endocrine, metabolic, and vascular pathways in premature birth. Microbiome-related literature links altered maternal vaginal and gut microbiota with pregnancy complications, suggesting immune and microbial dysregulation may contribute to early delivery.
Risk factors described in the grounding include maternal hypothyroidism, hyperthyroidism, and thyroid autoimmunity. Bacterial vaginosis and broader maternal gut or vaginal microbiota abnormalities are also associated with increased risk, and preterm birth itself is noted as a high-risk context for childbirth-related posttraumatic stress disorder.
AI-generated summary grounded in MeSH and 5 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.